Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,479	885	709	1,093	3,960	8,087
Market Cap Growth	166.66%	24.72%	-35.07%	-72.41%	-51.03%	117.39%
Enterprise Value	2,476	842	569	798	3,441	7,282
Last Close Price	16.24	6.00	4.90	7.64	28.06	59.13
PS Ratio	9.66	4.94	4.17	5.90	25.66	82.20
PB Ratio	12.12	4.37	2.30	2.35	6.56	10.88
P/TBV Ratio	29.76	11.02	3.85	3.23	8.31	13.17
EV/Sales Ratio	9.80	4.70	3.34	4.31	22.29	74.02
Debt / Equity Ratio	1.05	1.10	0.74	0.50	0.19	0.14
Asset Turnover	0.48	0.30	0.22	0.21	0.15	0.10
Inventory Turnover	8.07	7.79	6.65	4.48	11.50	11.98
Quick Ratio	3.11	2.71	4.38	4.91	3.27	6.66
Current Ratio	3.38	2.89	4.66	5.12	3.54	6.91
Return on Equity (ROE)	-37.21%	-62.49%	-58.34%	-37.52%	-30.77%	-22.25%
Return on Assets (ROA)	-9.32%	-16.18%	-16.60%	-14.06%	-12.81%	-9.42%
Return on Capital (ROIC)	-11.29%	-20.17%	-20.40%	-17.71%	-16.67%	-13.10%
Return on Capital Employed (ROCE)	-19.20%	-35.20%	-35.20%	-26.80%	-25.80%	-15.10%
Earnings Yield	-3.21%	-18.03%	-31.75%	-18.32%	-5.23%	-1.81%
FCF Yield	-2.54%	-11.18%	-23.54%	-18.33%	-6.43%	-2.08%
Buyback Yield / Dilution	-2.70%	-1.88%	-1.31%	-1.54%	-6.96%	-89.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q